Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar-Apr;53(2):174-175.
doi: 10.4103/ijp.IJP_785_19.

Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case

Erkan Cure  1 , Hakan Sirin  2 , Medine Cumhur Cure  3 , Dursun Ali Sahin  4
Affiliations

Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case

Erkan Cure et al. Indian J Pharmacol. 2021 Mar-Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

References

    1. Papakitsou I, Vougiouklakis G, Elisaf MS, Filippatos TD. Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes. Clin Pharmacol. 2019;11:133–43. - PMC - PubMed
    1. Simes BC, MacGregor GG. Sodium-glucose cotransporter-2 (SGLT2) inhibitors: A clinician's guide. Diabetes Metab Syndr Obes. 2019;12:2125–36. - PMC - PubMed
    1. [Last accessed on 2020 Oct 28]. Available from: https://www.drugs.com/sfx/dapagliflozin-side-effects.html .
    1. Apolzan JW, Venditti EM, Edelstein SL, Knowler WC, Dabelea D, Boyko EJ, et al. Long-term weight loss with metformin or lifestyle intervention in the diabetes prevention program outcomes study. Ann Intern Med. 2019;170:682–90. - PMC - PubMed

MeSH terms